Research Scholar Award
Dr. Steven Reynolds and his team received the award for their study that aims to help in the fight against antibiotic resistance, a problem that is made worse by the over-use of antibiotics
We are very pleased to announce that the 2011 FH Research Scholar Award has been awarded to Dr. Steven Reynolds, Medical and Research Director, RCH and Research Co-Director, SMH.
This $50,000 award provides one year of funding for up to one day a week of research time (up to a maximum of $35,000) and $15,000 to conduct a research project. The purpose of the award is to support FH employees or privileged physicians who have demonstrated success in conducting and completing research projects as Principal Investigators to become competitive for research funding at the national level. This is the first year that the Research Scholar award has been offered.
Dr. Reynolds and his study team received the award for their proposal entitled: A Pilot Study Evaluating a Procalcitonin-based Algorithm Determination of Antibiotic Duration in Critically Ill Patients. This study, which will be carried out at RCH and SMH aims to help in the fight against antibiotic resistance, a problem that is made worse by the over-use of antibiotics. This pilot study will help to plan a larger clinical trial that will evaluate whether procalcitonin can be used as a biomarker to indicate when to stop giving antibiotics to an ICU patient, thus preventing unnecessarily prolonged use of these drugs. Procalcitonin is a prehormone in our bodies that increases when we have an infection. Therefore, measuring procalcitonin levels could serve as an early signal when an infection is resolved and antibiotics are no longer needed.
Important to this project are the collaborations with external researchers at academic institutions both in Canada and in the US.
The co-applicants include:
We offer our congratulations to Dr. Reynolds and his team.